Last synced on 25 January 2026 at 3:41 am

PD-L1 IHC 28-8 pharmDx

Page Type
PMA Approval
PDF
PDF
* The FDA doesn't provide PDFs for all submissions.
Applicant
Agilent Technologies, Inc.
Trade Name
PD-L1 IHC 28-8 pharmDx
Generic Name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision Date
10/9/2015
Days to Decision
92 days
Decision Code
APPR
FDA Decision
Approval

PD-L1 IHC 28-8 pharmDx

Page Type
PMA Approval
PDF
PDF
* The FDA doesn't provide PDFs for all submissions.
Applicant
Agilent Technologies, Inc.
Trade Name
PD-L1 IHC 28-8 pharmDx
Generic Name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision Date
10/9/2015
Days to Decision
92 days
Decision Code
APPR
FDA Decision
Approval